Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134901) titled 'Exploring Quality Control in Minimally Invasive Techniques for Bile Duct Malignancies and Building a Precise Diagnosis and Treatment System' on Oct. 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Bile duct tumor
Intervention:
High-QC:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-22
Target Sample Size: High-QC:70;LOW qc:18;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=348768
Disclaimer: Curated by HT Syndication....